Want to join the conversation?
$XRAY said it expects constant currency sales growth to range from 4-6% in FY16, excluding precious metals. This includes a 1% net benefit from acquisitions, divestitures and discontinued products and internal growth of 3-5%. At current exchange rates, this translates to reported revenues, including precious metals, of about $3.73-3.81Bil.
$BABA seems to be on a roll! But increasing its yearly sales outlook from 48% to 54% seems over-expectation from the company's part, doesn't it?
$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?
$YHOO is reporting today after market close. Nobody cares about this stock.